FDA Approved: ZIPRASIDONE MESYLATE — Original Application (Novadoz Pharmaceuticals LLC)

View source ↗

Summary

FDA approved the original Abbreviated New Drug Application for ziprasidone mesylate from Novadoz Pharmaceuticals LLC, a generic version of ziprasidone.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizophrenia

Drugs mentioned

• Ziprasidone mesylate (Ziprasidone mesylate)

Snippet

ORIG AP for ZIPRASIDONE MESYLATE (ZIPRASIDONE MESYLATE)